Hyaluronic Acid Under Investigation for Asymptomatic COVID-19 Infection
High prevalence of asymptomatic COVID-19 (coronavirus) cases has become a matter of concern for healthcare institutions. Similarly, hyaluronic acid is under scrutiny for the occurrence of asymptomatic corona infection. Past studies have shown a correlation between high levels of hyaluronic acid and spots throughout the lungs in X-ray images, which is common in seriously ill COVID-19 patients. As such, there is a need for more evidence to make these claims strong enough for deep investigations.
Companies in the Latin America hyaluronic acid dermal filler market are suffering revenue losses since not many individuals are opting for cheek augmentation and other cosmetic treatments. Individuals are finding it important to spend on essential goods and services. As such, companies in the Latin America hyaluronic acid dermal filler market are expecting a revenue growth when the pandemic subsides in the first quarter of 2021.
Hyaluronic Acid: Superstar Ingredient for Nutricosmetics
Nutricosmetics are a novel introduction in the Latin America hyaluronic acid dermal filler market. People considering the intake of beauty-related dietary supplements are now opting for nutricosmetics in order to have youthful skin. In terms of volume, the Latin America hyaluronic acid dermal filler market is anticipated to expand at a CAGR of ~6% from 2020 to 2030. This is evident since hyaluronic acid and collagen have become the flagship ingredients for innovative nutricosmetics.
JLB Développement— a French manufacturer of health nutrition products, is making use of hyaluronic acid and collagen in its nutricosmetics, which promotes skin healing and moisturizing. Thus, skincare companies in Latin America are increasing their R&D in efficacy tests to utilize recognized ingredients for innovations in nutricosmetics. In order to gain market recognition, companies are backing their claims by conducting scientific studies in tandem with ingredient suppliers.
Diverse Portfolio of Injectable Technologies Helps Overcome Adverse Effects
Hyaluronic acid is rarely associated with severe side effects and allergic reactions. This explains why the Latin America hyaluronic acid dermal filler market is projected to reach a valuation of US$ 478.7 Mn by the end of 2030. However, several studies have shown that hyaluronic acid via injection route may produce adverse side effects and allergic reactions in some people. Hence, companies in the Latin America hyaluronic acid dermal filler market are educating people to consult dermatologists before indulging in any interactions with hyaluronic acid.
Manufacturers in Latin America are taking cues from Swiss companies to create a diverse portfolio of injectable technologies. For instance, Galderma— a Swiss pharmaceutical company specializing in dermatological treatments, has created a non-animal stabilized hyaluronic acid dermal filler, which has a proven safety record. Hyaluronic acid is being used to conduct reliable aesthetic treatments and increase volume in the cheek and lips.
REQUEST FOR COVID19 IMPACT ANALYSIS –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79720
Special Crosslinking Technologies Help Manufacturers Gain Efficacy in Injectable Technologies
Technological innovations have become a prerequisite for excelling in the Latin America hyaluronic acid dermal filler market. BioPolymer— a manufacturer of innovative injectable implants, is using the advanced thixotropic technology to increase the stability and durability of hyaluronic acid-induced products. Thus, companies in the Latin America hyaluronic acid dermal filler market are taking cues from such companies to increase the availability of high-quality skincare products.
Manufacturers are setting their collaboration wheels in motions to team up with doctors and patients to acquire proficiency in injectable technologies. However, optimizing the purity of hyaluronic acid dermal fillers in tandem with injection behavior is potentially challenging for manufacturers. Hence, manufacturers are increasing their research efforts in special crosslinking technologies to gain efficacy in injectable technologies.
Clean Production Paths Increase Availability of High-quality Anti-ageing Products
Clean production technologies pertaining to hyaluronic acid are more cost-intensive compared to traditional production methods. However, the quality and ethical thoughtfulness of such production methods tend to offset its high-cost production. For instance, Contipro— a producer of hyaluronic acid for the pharmaceutical and cosmetic industries, prefers clean production paths by extracting hyaluronic acid from the cell walls of the Streptococcus zooepidemicus bacteria. Latin America being socially and economically a backward country, the manufacturers here are learning insights from European hyaluronic acid dermal filler manufacturers to adopt clean production technologies.
Companies in the Latin America hyaluronic acid dermal filler market are increasing their research expenditure to gain a competitive edge over other market players, as skin-conscious individuals have catalyzed the demand for anti-ageing products. Manufacturers are increasing their production capabilities to develop active ingredients used in anti-ageing skincare products.
Resilient Skin Expert Treatments Fuel Demand for Hyaluronic Acid-induced Skincare Products
Hyaluronic acid dermal fillers are becoming increasingly commonplace in moisturizers. Its biocompatibility and technicality are being highly preferred by personal care brands. Moisturizers are being renewed with hyaluronic acid to develop an expertise in wrinkle filling through injections. Companies in the Latin America hyaluronic acid dermal filler market are tapping into business opportunities in cosmeceuticals to broaden their revenue streams. The expansion of product portfolio in hyaluronic acid-induced injection technologies is a recurring trend in the market landscape.
Apart from anti-ageing, hyaluronic acid is being used to resolve issues of dehydration, pigmentation, and imperfections related to the skin. Companies in the Latin America hyaluronic acid dermal filler market are adapting their production processes to develop consumables that align with the needs of users in dermatology clinics, hospitals, spas, and beauty institutes. The demand for hyaluronic acid dermal filler-induced products is being fueled with the introduction of resilient skin expert treatments.
Comments